News and Events

Past, Present, and Future of Cellular Immunotherapy: Scientific Symposium Celebrating Steven A. Rosenberg's 50 years at NCI

Date: September 26-27, 2024
Location: Masur Auditorium, Building 10

The symposium will discuss the development of cell therapy for the treatment of human cancer, from early studies from the Center for Cancer Research's Surgery Branch to current clinical and translational research being performed around the world. Sessions will focus on the initial development of cell therapy for patients with metastatic melanoma, the introduction of gene engineering into cell therapy, and the use of cell therapy to address common epithelial cancers.

2024 NCI RNA Biology Initiative Workshop

Date: April 23, 2024
Location: NCI Shady Grove

The NCI RNA Biology Initiative aims to create an inter-disciplinary environment to facilitate the rapid exchange of information and expertise on the structure, function, and biological roles of RNA and to foster synergistic interactions amongst NCI investigators. We anticipate that insights into RNA biology and the development of RNA-based tools will define novel targets and accelerate the implementation of therapeutic interventions in cancer.

This one-day workshop will include internal and external speakers with expertise in the topic area. The aim is to foster interaction among major laboratories in the areas of RNA Biology and to enhance the education and development of junior investigators and fellows in NCI laboratories.

Gene therapy proves successful in children with Wiskott-Aldrich syndrome

Wiskott-Aldrich syndrome (WAS) is a rare genetic disorder where males lack a gene critical for healthy blood and immune cell functioning. In a recent clinical trial, gene therapy for WAS was found to improve patients’ symptoms — an effect that was sustained for many years afterward.

Dr. Steve Rosenberg with President Biden

Steven Rosenberg receives the National Medal of Technology and Innovation

On October 24, 2023, President Biden awarded Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, the National Medal of Technology and Innovation for pioneering the development of immunotherapy. The award is the nation’s highest honor for technological achievement, bestowed by the president of the United States on America's leading innovators.

Clinical trial researches therapy for squamous cell carcinomas

Vassiliki Saloura, M.D., Ph.D., Stadtman Investigator in the Thoracic and GI Malignancies Branch, is leading CCR participation in a trial to research photoimmunotherapy with imaging for adults with head and neck or cutaneous squamous cell carcinoma.

New CAR T-cell therapy eliminates rhabdomyosarcoma in mice

After seeing excellent results of a CAR T-cell therapy against rhabdomyosarcoma in mice, a team of CCR researchers is preparing to test the immunotherapy in humans.

CCR Hosts “Frontiers in Basic Immunology” Symposium

CCR hosted a two-day international symposium, titled “Frontiers in Basic Immunology,” sponsored by the NCI Center of Excellence in Immunology (CEI). The program included a lineup of presentations from NCI and worldwide academic university speakers and a lively poster session.

Clinical trial researches radiation therapy for prostate tumors

A clinical trial led by Krishnan R. Patel, M.D., Assistant Research Physician in the Radiation Oncology Branch, is researching radiation therapy for prostate cancer.

The ups and downs of a rare blood cancer won’t stop one resilient patient

Even with a rare cancer diagnosis and a roller-coaster ride of a journey, Luis Miguel Cruz continues to find the motivation to keep moving forward through every setback. Along the way, he has inspired and brought joy to those he has met, both in person and digitally.

Clinical trial researches targeted therapy for biliary tract cancers

A clinical trial led by Jonathan M. Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching targeted therapy for cholangiocarcinoma and gallbladder cancer.

Breadcrumb